Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03409484 · ClinicalTrials.gov registry record · NA

Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults

A NA study of Appetitive Behavior and Glycemic Response, sponsored by Purdue University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03409484 is a NA study of Appetitive Behavior and Glycemic Response that has completed, run by Purdue University. The registered enrollment target is 40 participants, below the 54-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03409484, a NA study of Appetitive Behavior and Glycemic Response, has completed, sponsored by Purdue University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Assess the impact of 100% grape juice on postprandial glycemic response and subsequent appetite, food intake and cognitive function.

Interventions

  • OTHER Concord Grape Juice
  • OTHER Low flavoniod low essence beverage
  • OTHER Low flavonoid beverage

Study Locations (1)

Indiana

  • Purdue University - West Lafayette

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-10-10
Est. Completion 2019-09-20
Phase NA

Sponsor

Purdue University

141 total trials

What the Registry Record Tells You About NCT03409484

The ClinicalTrials.gov registry entry for NCT03409484 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 54-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (26% lower). The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Appetitive Behavior appearing as the primary indexed condition, and to 3 interventions - of which Concord Grape Juice is the first listed.

NCT03409484 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT03409484 about?

NCT03409484 is a clinical study titled "Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults". Assess the impact of 100% grape juice on postprandial glycemic response and subsequent appetite, food intake and cognitive function.

What is the current status of trial NCT03409484?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-10-10. Estimated completion is 2019-09-20.

What conditions does trial NCT03409484 study?

This clinical trial studies the following conditions: Appetitive Behavior, Glycemic Response.

What interventions are being tested in trial NCT03409484?

The interventions under investigation include: Concord Grape Juice (OTHER), Low flavoniod low essence beverage (OTHER), Low flavonoid beverage (OTHER).

Who is sponsoring clinical trial NCT03409484?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03409484 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Appetitive Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.